TABLE 1.
Group and mouse identification no. | No. of days after inoculation | CD4/CD8 ratio
|
% of CD4+ CD8+ cells in thymus | No. of RNA viral copies/ml | |
---|---|---|---|---|---|
Blood | Spleen | ||||
Uninfected control group (n = 15) | 2.92 ± 1.68 | 2.78 ± 1.46 | 67.8 ± 20.5 | ||
HIV-1JRCSF-infected group | |||||
1 | 30 | 1.86 | 0.88 | 77.1 | 9,078 |
2 | 30 | 0.46 | 0.53 | 12.5 | 7,703 |
3 | 33 | 2.61 | 2.17 | 85.7 | 223,020 |
4 | 63 | 0.17 | 0.27 | 25.5 | 9,965 |
5 | 63 | 0.36 | 0.44 | 27.2 | 8,734 |
6 | 63 | 0.18 | 0.88 | 69.6 | 42,198 |
7 | 90 | 0.03 | 0.37 | 82.5 | 24,441 |
8 | 90 | 0.30 | 0.79 | 84.6 | 24,454 |
9 | 90 | 1.77 | 1.55 | 56.9 | 80,636 |
10 | 109 | 0.20 | 0.17 | 43.4 | 470,392 |
11 | 116 | 0.09 | 0.78 | 11.8 | 299,080 |
HIV-1MNp-infected group | |||||
1 | 31 | 0.82 | 0.44 | 34.6 | 3,709,520 |
2 | 31 | 1.02 | 0.61 | 90.2 | 219,971 |
3 | 31 | 1.64 | 1.57 | 78.2 | 135,592 |
4 | 59 | 0.21 | 0.38 | 35.4 | 78,848 |
5 | 59 | 0.10 | 0.07 | 77.0 | 1,039,716 |
6 | 87 | 0.20 | 0.40 | 0.5 | 49,080 |
7 | 87 | 0.19 | 0.08 | 11.7 | 121,817 |
8 | 91 | 0.04 | 0.04 | 82.9 | 30,706 |
9 | 91 | 0.28 | 0.10 | 1.2 | 7,407 |
10 | 109 | 0.00 | 0.21 | 2.8 | 17,310 |
HIV-1NL4-3-infected group | |||||
1 | 32 | 1.01 | 0.81 | 64.5 | 195,375 |
2 | 32 | 0.03 | 0.05 | 4.6 | 770,721 |
3 | 60 | 0.21 | 0.13 | 3.9 | 1,108,003 |
4 | 60 | 0.14 | NDb | ND | 328,375 |
5 | 87 | 0.03 | 0.04 | 1.0 | 201,207 |
6 | 92 | 0.03 | 0.17 | 11.1 | 90,831 |
7 | 92 | 0.03 | 0.03 | 1.4 | 135,514 |
8 | 112 | 0.30 | 0.23 | 0.2 | 325,202 |
Twenty-nine mice inoculated with R5-tropic HIV-1JRCSF (n = 11), X4-tropic HIV-1MNp (n = 10), or X4-tropic HIV-1NL4-3 (n = 8) were sacrificed 161 to 249 days after HSC transplantation. Fifteen uninfected control mice were sacrificed 174 to 249 days after transplantation, and results for the control group are expressed as means ± standard deviations.
ND, not determined because of a lack of cells.